Literature DB >> 7408366

Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

R B Patel, P G Welling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7408366     DOI： 10.2165/00003088-198005050-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  107 in total

1.  Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis.

Authors:  M I Marks; M Kazemi; B Hales; A H Neims
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.

Authors:  M C Bach; O Gold; M Finland
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Sulphamethoxazole-trimethoprim: the first two years.

Authors:  D S Reeves
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

4.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

5.  Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.

Authors:  D E Schwartz; W Vetter; G Englert
Journal:  Arzneimittelforschung       Date:  1970-12

6.  Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children.

Authors:  M I Marks
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

7.  Use of co-trimoxazole in chronic renal failure.

Authors:  P R Tasker; G A MacGregor; H E de Wardener
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

8.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

9.  Deterioration in renal function in association with co-trimoxazole therapy.

Authors:  R R Bailey; P J Little
Journal:  Med J Aust       Date:  1976-06-12       Impact factor: 7.738

10.  Trimethoprim resistance in Finland after five years' use of plain trimethoprim.

Authors:  P Huovinen; P Toivanen
Journal:  Br Med J       Date:  1980-01-12
View more
  25 in total

1.  Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.

Authors:  M A Kielhofner
Journal:  Tex Heart Inst J       Date:  1990

2.  Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma.

Authors:  Esin Sayar; Selma Sahin; Semsettin Cevheroglu; A Atilla Hincal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.

Authors:  B L Lee; S Safrin; V Makrides; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

6.  Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.

Authors:  Claire Pressiat; Veronique Mea-Assande; Caroline Yonaba; Jean-Marc Treluyer; Désiré-Lucien Dahourou; Madeleine Amorissani-Folquet; Stéphane Blanche; François Eboua; Diarra Ye; Gabrielle Lui; Karen Malateste; Yi Zheng; Valeriane Leroy; Déborah Hirt
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

7.  Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.

Authors:  J E Svirbely; A J Pesce; S Singh; E J O'Flaherty
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 8.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

9.  Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.

Authors:  Allen C Cheng; Emma S McBryde; Vanaporn Wuthiekanun; Wirongrong Chierakul; Premjit Amornchai; Nicholas P J Day; Nicholas J White; Sharon J Peacock
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

10.  Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.

Authors:  T W Chin; A Vandenbroucke; I W Fong
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.